Cargando…

Influence of standard modifiable risk factors on ventricular tachycardia after myocardial infarction

BACKGROUND: Inducible ventricular tachycardia (VT) at electrophysiology study (EPS) predicts sudden cardiac death because of ventricular tachyarrhythmia, the single greatest cause of death within 2 years after myocardial infarction (MI). OBJECTIVES: We aimed to assess the association between standar...

Descripción completa

Detalles Bibliográficos
Autores principales: Deshmukh, Tejas, Kovoor, Joshua G., Byth, Karen, Chow, Clara K., Zaman, Sarah, Chong, James J. H., Figtree, Gemma A., Thiagalingam, Aravinda, Kovoor, Pramesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628449/
https://www.ncbi.nlm.nih.gov/pubmed/37942068
http://dx.doi.org/10.3389/fcvm.2023.1283382
Descripción
Sumario:BACKGROUND: Inducible ventricular tachycardia (VT) at electrophysiology study (EPS) predicts sudden cardiac death because of ventricular tachyarrhythmia, the single greatest cause of death within 2 years after myocardial infarction (MI). OBJECTIVES: We aimed to assess the association between standard modifiable risk factors (SMuRFs) and inducible VT at EPS early after MI. METHODS: Consecutive patients with left ventricle ejection fraction ≤40% on days 3–5 after ST elevation MI (STEMI) who underwent EPS were prospectively recruited. Positive EPS was defined as induced sustained monomorphic VT cycle length ≥200 ms for ≥10 s or shorter if hemodynamically compromised. The primary outcome was inducibility of VT at EPS, and the secondary outcome was all-cause mortality on follow-up. RESULTS: In 410 eligible patients undergoing EPS soon (median of 9 days) after STEMI, 126 had inducible VT. Ex-smokers experienced an increased risk of inducible VT [multivariable logistic regression adjusted odds ratio (OR) 2.0, p = 0.033] compared with current or never-smokers, with comparable risk. The presence of any SMuRFs apart from being a current smoker conferred an increased risk of inducible VT (adjusted OR 1.9, p = 0.043). Neither the number of SMuRFs nor the presence of any SMuRFs was associated with mortality at a median follow-up of 5.4 years. CONCLUSIONS: In patients with recent STEMI and impaired left ventricular function, the presence of any SMuRFs, apart from being a current smoker, conferred an increased risk of inducible VT at EPS. These results highlight the need to modify SMuRFs in this high-risk subset of patients.